Radiotherapy Prolongs Biliary Metal Stent Patency in Malignant Pancreatobiliary Obstructions

Background/Aims Biliary stenting is the most effective decompressive method for treating malignant biliary obstructive jaundice. Although the main cause of stent occlusion is tumor growth, few studies have investigated whether stent patency is affected by the combination of cancer-treatment modalities. The aim of this study was to evaluate the effects of local radiotherapy on metal-stent patency in patients with malignant biliary obstruction. Methods Patients who underwent self-expandable biliary metallic stenting for malignant biliary obstruction from 1999 to 2007 were included. Forty patients received chemotherapy and radiation therapy (radiation group, RG), and 31 patients received only chemotherapy (nonradiation group, NRG). Results The cumulative median stent patency was significantly longer in the RG than in the NRG (17.7 months; 95% confidence interval [CI], 1.8 to 33.6 months vs 8.7 months; 95% CI, 4.9 to 12.5 months; p=0.025). Stent occlusion caused by tumor growth or stent migration occurred in two (5%) and three (7.5%) cases in the RG and in six (19.3%) and two (6.5%) cases in the NRG, respectively. Conclusions The patency of biliary metal stents in pancreatobiliary cancer patients who receive chemoradiation therapy is significantly longer than that in patients who do not receive radiotherapy, which suggests that local cancer control significantly affects stent patency.

[1]  M. Zong,et al.  Clinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma. , 2011, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[2]  R. Srinivasan,et al.  Major Molecular Markers in Pancreatic Ductal Adenocarcinoma and Their Roles in Screening, Diagnosis, Prognosis, and Treatment , 2011, Pancreas.

[3]  T. Song,et al.  Surgical Outcomes and Prognostic Factors for Ampulla of Vater Cancer , 2011, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[4]  F. Jiao,et al.  p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies , 2011, Digestive Diseases and Sciences.

[5]  S. Barreto,et al.  Systematic Review: Should Routine Resection of the Extrahepatic Bile Duct Be Performed in Gallbladder Cancer? , 2010, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[6]  Jeong Kyun Seo,et al.  A comparison of the Niti-D biliary uncovered stent and the uncovered Wallstent in malignant biliary obstruction. , 2009, Gastrointestinal endoscopy.

[7]  T. Jeon,et al.  Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer , 2008, British Journal of Cancer.

[8]  V. Valek,et al.  Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study. , 2007, European journal of radiology.

[9]  V. G. Rao,et al.  Impact of reducing duodenobiliary reflux on biliary stent patency: an in vitro evaluation and a prospective randomized clinical trial that used a biliary stent with an antireflux valve. , 2007, Gastrointestinal endoscopy.

[10]  P. Macmathuna,et al.  Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. , 2007, Cancer treatment reviews.

[11]  R. Marmo,et al.  Endoscopic palliation of malignant obstructive jaundice: an evidence-based review. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[12]  J. Tokar,et al.  Covered self-expandable metal stents in pancreatic malignancy regardless of resectability: a new concept validated by a decision analysis , 2005, Endoscopy.

[13]  N. Fujita,et al.  Endoscopic biliary drainage for patients with unresectable pancreatic cancer with obstructive jaundice who are to undergo gemcitabine chemotherapy. , 2006, World journal of gastroenterology.

[14]  N. Rahim,et al.  The role of covered self-expandable metallic stents in malignant biliary strictures. , 2006, Gastrointestinal endoscopy.

[15]  K. Lee,et al.  A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. , 2006, Gastrointestinal endoscopy.

[16]  S. Linder,et al.  Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. , 2006, Gastrointestinal endoscopy.

[17]  R. Zhai,et al.  Treatment of malignant biliary obstruction by combined percutaneous transhepatic biliary drainage with local tumor treatment. , 2006, World journal of gastroenterology.

[18]  B. Petersen,et al.  A Novel Endoscopic Approach to Brachytherapy in the Management of Hilar Cholangiocarcinoma , 2005, The American Journal of Gastroenterology.

[19]  I. Panagiotou,et al.  A Survival Analysis of Patients with Malignant Biliary Strictures Treated by Percutaneous Metallic Stenting , 2007, CardioVascular and Interventional Radiology.

[20]  Kenneth J. Chang,et al.  Endoscopic palliation of pancreatic adenocarcinoma , 2005, Current opinion in gastroenterology.

[21]  M. Freeman,et al.  Endoscopic therapy of benign biliary strictures. , 2005, Reviews in gastroenterological disorders.

[22]  Y. Shiratori,et al.  A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction , 2004, Gut.

[23]  J. Llach,et al.  Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. , 2002, Radiology.

[24]  I. Endo,et al.  Adjuvant therapies using biliary stenting for malignant biliary obstruction. , 2001, Journal of hepato-biliary-pancreatic surgery.

[25]  M. Conio,et al.  Endoscopic treatment of pancreatico-biliary malignancies. , 2001, Critical reviews in oncology/hematology.

[26]  T. Bowling,et al.  A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. , 1996, Gut.

[27]  D. Hovsepian,et al.  Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy. , 1996, Radiology.

[28]  F. Halter,et al.  Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. , 1996, The American journal of gastroenterology.